BC Platforms
BC Platforms is a Swiss-headquartered data and technology company that builds AI-powered trusted research environments, data mastering, and analytics software for top-20 pharmaceutical companies and 150+ healthcare organizations, backed by a global real-world data network covering 187M+ patient lives across 35+ countries.
- Company typePrivate
- Founded1997
- HeadquartersZürich, Switzerland
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What BC Platforms does
BC Platforms AG is a Zürich-headquartered, privately-held data and technology company founded in 1997 that builds software and curated real-world data infrastructure for personalized and precision medicine. Its modular platform centers on BC Unify, an AI-driven data mastering engine that ingests, harmonizes, transforms and enriches multi-modal data (clinical, EMR, eCRF, lab, multi-omics and imaging); BC Mosaic, an EHDS-ready Trusted Research Environment deployed on AWS with native NVIDIA GPU acceleration and Flower Labs federated learning; BC Catalyst, a proprietary agentic AI analytics layer exposing prompt-based queries over harmonized genomic and RWD; BC Image, an AI-driven medical image de-identification and processing module; and BC Data, a global real-world data network aggregating 187M+ patient lives across 35+ countries via 150+ data partners.
The company sells primarily through enterprise contracts and subscriptions to top-20 pharmaceutical companies and 150+ healthcare organizations (university hospitals, biobanks, research institutions), with BC Mosaic also listed on AWS Marketplace for pay-as-you-go procurement. Revenue is generated via recurring enterprise subscriptions for BC Mosaic, BC Unify, BC Image and BC Data, BC Catalyst subscription analytics, professional services led by the Global Head of Technology and Data Services, and revenue-sharing arrangements with hospitals that commercialize anonymized datasets through the global data partner network. Distribution combines direct enterprise field sales with regional leadership (e.g., SVP APAC & Japan), hyperscaler co-selling (AWS, NVIDIA), and consortium participation (TEHDAS2, EHDS2 reference architecture with Modirum Platforms, VEIL.AI, Productivity Leap).
BC Platforms firmographics
Firmographics- Name
- BC Platforms
- Legal name
- BC Platforms AG
- Website
- https://bcplatforms.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- BC Platforms is a Swiss-headquartered data and technology company that builds AI-powered trusted research environments, data mastering, and analytics software for top-20 pharmaceutical companies and 150+ healthcare organizations, backed by a global real-world data network covering 187M+ patient lives across 35+ countries.
- Ownership category
- akta.pro rank
BC Platforms industry classification
Industry- Product category
- Healthcare Real-World Data & Precision Medicine Analytics
- NAICS
- Scientific Research and Development Services (5417), Software Publishers (5132)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
Keywords
Where BC Platforms is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
BC Platforms business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- BC Catalyst Subscription: BC Catalyst is offered by subscription to pharmaceutical, biotech and medtech organizations; pricing model is described as 'Available by subscription' leveraging the proprietary agentic AI platform.
- BC Mosaic, BC Unify, BC Image and BC Data Enterprise Subscriptions: Recurring enterprise contracts for the BC Mosaic trusted research environment (available on AWS Marketplace), BC Unify data mastering platform, BC Image medical image processing platform, and BC Data global real-world data network serving life sciences and healthcare customers.
- Scientific & Technology Consulting Services: Expert guidance for evidence generation, data integration, scalable analytics and AI, led by Narasimha Kumar (Global Head of Technology and Data Services); delivery of consulting across technology, data, and regulated environments.
- Healthcare Data Monetization via Global Data Partner Network: Revenue-sharing programs with healthcare institutions joining the global data partner network ('anonymize, monetize, and safely store your treatment data… share in revenue-based projects'), enabling hospitals to commercialize anonymized datasets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | — | BC Catalyst available by subscription |
| Other | — | BC Mosaic listed on AWS Marketplace |
Go-to-market motion5 records
Distribution channels6 records
Marketing channels8 records
BC Platforms product offering
Product offeringCore offering
BC Platforms provides a modular AI-driven platform (BC Unify, BC Catalyst, BC Mosaic, BC Image) for ingesting, harmonizing and analyzing clinical, genomic, multi-omics and imaging real-world data, supported by a global network of 150+ data partners covering 187M+ patient lives across 35+ countries. The offering targets life sciences companies and healthcare institutions with EHDS-ready Trusted Research Environments, federated analytics and AI-native precision medicine tools across the drug development lifecycle, complemented by Scientific & Technology Consulting services.
Product overview
BC Platforms offers a modular, AI-driven platform-plus-modules architecture for global healthcare data management and analytics across the drug development lifecycle. The core data mastering platform BC Unify ingests, harmonizes, and enriches multi-modal research-ready data; BC Mosaic is the AI-powered Trusted Research Environment (TRE) where compliant analysis, federated learning (via Flower Labs), and NVIDIA-accelerated computing are deployed; BC Catalyst is the proprietary agentic AI analytics layer that consumes BC Unify data via prompt-based queries; BC Image is the computer-vision module for medical imaging; and BC Data is the underlying global real-world data network of 150+ partners covering 187M+ patient lives across 35+ countries. Scientific & Technology Consulting wraps the platform with expert services, while acquired brands 4Pharma and Medexprim extend clinical trial and clinical-imaging real-world data capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- BC Unify: AI-driven, end-to-end data mastering platform that ingests, harmonizes, transforms, and enriches multi-modal data to power other BC Platforms solutions.
- BC Catalyst
- BC Image
- BC Mosaic
- BC Data
Products and services
- BC Unify End-to-end AI-driven data mastering platform that ingests, harmonizes, transforms and enriches clinical, EMR, eCRF, lab, multi-omics and imaging data into research-ready datasets; powers downstream BC Catalyst and BC Mosaic analytics for life sciences and healthcare customers.
- BC Catalyst First-to-market AI-native analytics platform using a proprietary agentic AI model and prompt-based natural language interface to transform genomic and real-world clinical data into actionable insights across the full drug lifecycle — cohort identification, biomarker discovery, drug target identification, genetic variant interpretation and standards-of-care analysis. Available by subscription to pharma, biotech and medtech organizations.
- BC Mosaic Next-generation AI-powered Trusted Research Environment (TRE) for clinical, genomic and multi-omics studies. Listed on AWS Marketplace; integrates NVIDIA GPU acceleration and Flower Labs federated machine learning; provides multi-tier role-based access, federated research, audit trails and significantly reduced deployment times for healthcare and life sciences customers preparing for EHDS.
- BC Image AI-driven, end-to-end platform that automates extraction, de-identification, processing and contextual augmentation of medical images (X-Rays, MRIs, CT scans). Powered by NVIDIA CUDA; deployed across European hospitals to de-identify and harmonize millions of images per week while remaining GDPR compliant.
- BC Data Global real-world data network providing curated clinical, EMR, eCRF, lab, multi-omics and imaging datasets across oncology, neurology, rare diseases, immunology and other therapeutic areas. Accessed through 150+ global data partners and covering 187M+ patient lives across 35+ countries, with >90% of patients outside the US.
- Scientific & Technology Consulting Expert consulting services covering evidence generation, data integration, scalable analytics and AI strategy for life sciences and healthcare clients. Delivered globally under the Technology Consulting practice led by Narasimha Kumar, Global Head of Technology and Data Services.
- EHDS-Ready Trusted Research Environment Hardware-agnostic, EHDS-ready Trusted Research Environment for EU healthcare institutions needing to comply with European Health Data Space regulations. Supports OMOP CDM, FHIR and openEHR standards, federated analysis and AI-based tools across local and national secure data environments.
Quantifiable outcome
- Up to 80x faster AI-driven analytics across multi-modal health data versus traditional CPU-only processing
- +5 more outcomes
Companies that use BC Platforms
Customer profileNamed customers19 records
Segments4 records
Ideal customer profiles3 records
BC Platforms technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability11 records
Feature8 records
BC Platforms partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core, flagship and minor.
- Flower LabscoreBC Platforms partnered with Flower Labs to integrate the Flower SuperGrid and Flower Framework inside BC Mosaic TRE, enabling federated machine learning across distributed clinical, real-world and multi-modal data without moving sensitive data. Each organization can deploy a Flower SuperNode within its environment while SuperGrid coordinates workflows across participating sites, supporting EHDS-compliant multi-institutional AI development.
- AWS MarketplacecoreBC Mosaic trusted research environment is published on AWS Marketplace, allowing AWS customers to procure and deploy BC Mosaic through the marketplace as part of the AWS Strategic Collaboration Agreement.
- Amazon Web Services (AWS)flagshipBC Platforms signed a Strategic Collaboration Agreement (SCA) with AWS to enhance the BC Mosaic trusted research environment, scale secure AI-powered research environments, and prepare customers for the European Health Data Space (EHDS). The collaboration includes joint go-to-market initiatives, AWS Marketplace availability of BC Mosaic, co-selling activities, and the use of AWS Bedrock, SageMaker and other ML/AI services within BC Mosaic. BC Mosaic runs natively on AWS cloud infrastructure and supports genomic and clinical datasets from 187M+ patient lives across 35+ countries.
- NVIDIAflagshipNVIDIA technologies are natively integrated into BC Mosaic and BC Image. The integration delivers out-of-the-box access to NVIDIA GPUs, NVIDIA Rapids, cuDF, cuGraph, NetworkX and CUDA within the BC Mosaic trusted research environment, enabling up to 80x faster AI-driven analytics across multi-modal datasets (e.g., cuDF vs. pandas benchmarks on T4 GPUs / AWS EC2 G4 instances). BC Image already uses NVIDIA CUDA for high-volume medical image de-identification and processing.
- OmicsBankcoreStrategic partnership to expand access to large-scale real-world and multi-omics datasets from India (~12 million patients) and the UAE (~500,000 patients), with plans for further expansion into Saudi Arabia, Taiwan, the Philippines and Malaysia. The collaboration addresses the under-representation of South Asian populations (<2%) in global genome-wide association studies and brings BC Platforms' global patient catchment to over 187 million patient lives across 35+ countries.
- GeneVault LifesciencescoreStrategic partnership integrating GeneVault's network of over 115 medical facilities and 120 hospitals in Asia, the Middle East, Africa and Latin America into BC Platforms' BC Unify data mastering platform. Adds 48 million patient lives across 13 countries, expanding BC Platforms' global data partner network to 175M+ patient lives across 35+ countries, spanning oncology, immunology, neurology, cardiology and rare diseases.
- National Health Research Institutes (NHRI) TaiwancoreCo-development partnership for the HARBOR Trusted Research Environment using the UK Five Safes model (Safe People, Safe Projects, Safe Settings, Safe Data, Safe Output); enables compliant and secure research at scale. NHRI is exploring cross-border collaborations including with Singapore's A*STAR.
- Yonsei University Health SystemminorCo-organized Smart Healthcare International Symposium with AWS and BC Platforms; Yonsei presented its hybrid-cloud data lake architecture (Y-KNOT bilingual LLM) linking on-premise data lakes to AWS via VPN for clinical workflows.
- Academia Sinica and Asia University (Taiwan)minorAWS is collaborating with Academia Sinica and Asia University to support the Healthy Taiwan initiative within the new AWS Asia Pacific (Taipei) Region; BC Platforms participates as a key data partner in the forum.
- NTT entities (Japan Precision Medicine Platform)coreBC Platforms AG collaboration with NTT entities on the Japan Precision Medicine Platform (April 2024), cited as a key recent development in the precision medicine software market.
- Modirum PlatformscoreCo-development partner for the EHDS2 reference architecture. Modirum Platforms provides software for Health Data Access Bodies and Trusted Data Holders (often university hospitals) to automate EHDS2-compliant data request and data access approval processes, including cybersecurity controls.
- VEIL.AIcoreCo-development partner for the EHDS2 reference architecture. VEIL.AI provides next-generation AI-enhanced anonymization and synthetization technology that preserves critical data relationships in anonymized datasets, ensuring EHDS-compliant data release.
- Productivity LeapcoreFinnish IT consulting company (part of Digia Group) and EHDEN-certified SME partner; provides EHR data mapping to OMOP CDM, harmonization services and integration projects that feed the EHDS2 reference architecture pipeline.
- MedexprimcoreBC Platforms acquired Medexprim, a French real-world data company, expanding its ability to offer clinical and imaging data across Europe. Deal terms were undisclosed; the acquisition follows the earlier acquisition of 4Pharma and is cited as creating the world's largest health data network focused on precision medicine and real-world evidence analytics.
- 4PharmacoreBC Platforms acquired 4Pharma, a provider of medical research data and services, expanding its global clinical trial and real-world data capabilities and enhancing its service portfolio in healthcare data management and analytics, with an emphasis on precision medicine and data privacy.
- Helsinki University Hospital (HUS) and Findata ecosystemcoreBC Platforms' software is deployed in Finnish health data research environments, including HUS which receives ~800 data requests annually (~95% internal) leading to ~200 projects with granted data access. The platform automates Data Discovery, Data Access Application Management, Data Release and Secure Processing Environment for federated analyses; Finland is the first country to have secondary and biobank laws and an official Health Data Access Body (HDAB).
- HDR UK (Health Data Research UK) and 11 NHS TrustscoreBC Platforms' software is used to implement the HDR-UK real-time data availability query service that combines 11 NHS Trusts in one federated platform, providing a benchmark for EHDS-style deployment.
- TEHDAS2 consortium (EU)flagshipBC Platforms is part of the TEHDAS2 stakeholder forum developing universal guidelines and technical specifications for the secondary use of health data under EHDS, contributing via its R&D center in Espoo, Finland.
- University of British Columbia, University of Nottingham, Imperial College Healthcare NHS Trust, NHS University Hospital Southampton, Medical University of Graz Biobank, University of Tartu Estonian Genome Center, UniKlinikum Wurzburg, Institut Gustave Roussy, Centre Antoine Lacassagne, Centre Leon Berard, Hopital Foch, Hopital Saint-Joseph Marseille, OncoValue, IDx Lung, Helios Health (Singapore), Technology Industries of FinlandminorFeatured customer logos on bcplatforms.com representing the global data partner network across university hospitals, biobanks, research institutions and industry partners feeding the BC Unify data mastering platform.
- A*STAR SingaporeminorCross-border research discussions between NHRI Taiwan and Singapore's A*STAR for the HARBOR TRE platform; BC Platforms participates as data partner in the regional ecosystem.
Scale indicators11 records
Recent moves6 records
Expansion highlights7 records
BC Platforms competitors and assessment
Company assessmentEmerging players
- Owkin: Owkin combines federated AI and real-world patient data for pharma and academic research, overlapping with BC Platforms' federated learning and EHDS-style use cases from a more AI-first angle.
Direct peers
- TriNetX: TriNetX operates a global federated health research network used by top pharmas for trial feasibility, real-world evidence and cohort queries, directly competing with BC Data and BC Catalyst.
- Velsera (formerly Seven Bridges): Velsera provides a biomedical informatics platform for genomics, transcriptomics and clinical research, with federated and TRE capabilities directly comparable to BC Platforms' offerings.
- Datavant: Datavant focuses on privacy-preserving linking and exchange of real-world health data, closely related to BC Platforms' data mastering, de-identification and federated research capabilities.
- Lifebit: Lifebit builds federated genomics and biomedical data platforms with Trusted Research Environments, positioning it as a direct competitor to BC Mosaic in pharma and population genomics.
- DNAnexus: DNAnexus operates a cloud-based biomedical data analysis and collaboration platform for genomics and clinical research, directly competing with BC Mosaic TRE and BC Unify in the federated genomics/RWE category.
Broad incumbents
- IQVIA (E360 / Orchestrated Patient Cloud): IQVIA is a deep incumbent in clinical research and real-world evidence with a federated data network; an existing BC Platforms investor (2019 round) and a broad incumbent competing for similar pharma RWD and analytics budgets.
- Tempus Labs: Tempus combines multi-modal clinical and genomic data with AI for precision medicine, overlapping with BC Platforms on pharma R&D analytics, biomarker discovery and clinical-genomic data networks.
- Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving hospital systems and life sciences; broader in scope than BC Platforms but competes for healthcare institution analytics and TRE-style budgets.
- Palantir Technologies (Foundry for Health / FedStart): Palantir Foundry underpins several large biomedical data initiatives (e.g., NIH, UK NHS federated programs) and competes with BC Platforms for enterprise health data analytics and TRE deployments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat8 records
Key risks7 records
Key highlights7 records
Customer concentration
BC Platforms social profiles
Digital presenceBC Platforms compliance and trust
Trust signalCompliance12 records
BC Platforms financial estimates
Financial estimateRevenue estimate
Valuation estimate
BC Platforms leadership team
Management profileNumber of profiles
Profiles12 records
BC Platforms subsidiaries and ownership
Company hierarchySubsidiaries2 records
BC Platforms funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BC Platforms M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BC Platforms
What does BC Platforms do?
BC Platforms provides a modular AI-driven platform (BC Unify, BC Catalyst, BC Mosaic, BC Image) for ingesting, harmonizing and analyzing clinical, genomic, multi-omics and imaging real-world data, supported by a global network of 150+ data partners covering 187M+ patient lives across 35+ countries. The offering targets life sciences companies and healthcare institutions with EHDS-ready Trusted Research Environments, federated analytics and AI-native precision medicine tools across the drug development lifecycle, complemented by Scientific & Technology Consulting services.
Is BC Platforms a public or private company?
BC Platforms is a private company. It is classified as venture growth investor backed and is currently operating.
When was BC Platforms founded?
BC Platforms was founded in 1997. It employs 101 to 250 people.
Where is BC Platforms based?
BC Platforms is headquartered in Zürich, Switzerland, in the Europe region.
How does BC Platforms make money?
Four revenue lines are on record. BC Catalyst Subscription is the primary driver. The others are BC Mosaic, BC Unify, BC Image and BC Data Enterprise Subscriptions, scientific & Technology Consulting Services and healthcare Data Monetization via Global Data Partner Network.
Who are BC Platforms's main competitors?
Owkin is listed as an emerging player. Direct peers are TriNetX, Velsera (formerly Seven Bridges), Datavant, Lifebit and DNAnexus. Broad incumbents are IQVIA (E360 / Orchestrated Patient Cloud), Tempus Labs, Health Catalyst and Palantir Technologies (Foundry for Health / FedStart).
Does BC Platforms have an API?
No public API is recorded for BC Platforms.
What industry is BC Platforms in?
BC Platforms's product category is Healthcare Real-World Data & Precision Medicine Analytics. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5417 and its SIC code is 3826.